63 results
Page 2 of 4
424B5
i093xx23oeii80
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-1.1
u2xek2szdhxbrg8j8zu
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
txql5rt2 eo4n94ujp
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
yxg8k0c8mw2 hsxm
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
tqdl7
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
EX-12.1
crkmx kxgh
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.2
ec3ablw3fx9
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
blk xf0tark41
23 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.1
53h w9pi6vmo4teem
23 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.2
fyuu18i wu
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
m7f0ib1g
20 Nov 19
Prospectus supplement for primary offering
4:46pm
424B3
dsnloareko pnpwkv
10 Jul 19
Prospectus supplement
8:18am
F-3
uc2jrvim6tprtl
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
dvdw0q6wvz6oguwc
7 Jun 19
Shelf registration (foreign)
3:31pm